Newsroom

LONDON--(BUSINESS WIRE)--  Re: MORTIMER BTL 2023-1 PLC GBP 21,418,000.00 MATURING: 22-Dec-2056 ISIN: XS2712034540 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 23-Mar-2026 HAS BEEN FIXED AT 5.76 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: GBP 323,929.74 PER GBP 22,546,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: ORBITA FUNDING 2023-1 PLC GBP 39,923,000.00 MATURING: 22-Oct-2030 ISIN: XS2699151291 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 23-Feb-2026 TO 23-Mar-2026 HAS BEEN FIXED AT 5.63 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: GBP 172,533.86 PER GBP 39,923,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: MORTIMER BTL 2023-1 PLC GBP 348,532,000.00 MATURING: 22-Dec-2056 ISIN: XS2712034466 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 23-Mar-2026 HAS BEEN FIXED AT 4.93 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: GBP 2,223,281.49 PER GBP 180,781,213.85 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: MORTIMER BTL 2023-1 PLC GBP 7,788,000.00 MATURING: 22-Dec-2056 ISIN: XS2712034979 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 23-Mar-2026 HAS BEEN FIXED AT 7.81 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 23-Mar-2026 WILL AMOUNT TO: GBP 159,684.43 PER GBP 8,198,000.00 DENOMINATION  ...

PARIS--(BUSINESS WIRE)--Truffle Capital, eine führende europäische Risikokapitalgesellschaft mit der Mission, die Gründung und das Wachstum von Unternehmen zu fördern, die das Potenzial haben, zu globalen Marktführern zu werden, stellt heute den Truffle MedTech 10 Index vor. Dabei handelt es sich um das erste Ranking der zehn börsennotierten Unternehmen mit der höchsten Marktkapitalisierung im Bereich interventioneller Medizintechnik in der vorkommerziellen und frühen kommerziellen Phase. Auf G...

PARIS--(BUSINESS WIRE)--Truffle Capital, un des leaders européens du venture capital dont la mission est de soutenir la création et la croissance d'entreprises capables de devenir des leaders mondiaux, dévoile l'indice Truffle MedTech 10. Il s'agit du premier classement des dix premières capitalisations boursières dans le secteur de la MedTech interventionnelle en phase pré-commerciale ou en phase de commercialisation initiale. S'appuyant sur les données de PitchBook (https://pitchbook.com) au...

PARIS--(BUSINESS WIRE)--Truffle Capital, a leading European venture capital firm whose mission is to support the creation and growth of companies capable of becoming global leaders, unveils the Truffle MedTech 10 index. This is the first ranking of the top ten publicly traded companies by market capitalization in the pre-commercial and early commercial interventional MedTech sector. Using PitchBook (https://pitchbook.com) data as of March 12th, 2026, this list identifies companies developing me...

CHAILLÉ-SOUS-LES-ORMEAUX, France--(BUSINESS WIRE)--Regulatory News : Hoffmann Green Cement Technologies (ISIN : FR0013451044, Mnémo : ALHGR) (« Hoffmann Green Cement » ou la « Société »), acteur industriel engagé dans la décarbonation du secteur de la construction qui conçoit et commercialise des ciments innovants sans clinker, annonce la signature d’un partenariat stratégique avec Le Coq Construction, spécialiste du gros œuvre en construction et rénovation, renforçant ainsi son ancrage territo...

CHAILLÉ-SOUS-LES-ORMEAUX, France--(BUSINESS WIRE)--Regulatory News: Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) (“Hoffmann Green Cement” or the “Company”), an industrial player committed to the decarbonation of the construction sector that designs and markets innovative cold produced, clinker-free cements, announces the signing of a strategic partnership with Le Coq Construction, a specialist in structural work for new construction and renovation, thereby strengthenin...

HELSINKI & LONDON--(BUSINESS WIRE)--Epassi Group, a leading European multi-benefits technology platform, today announced the appointments of Phil Jones as Chief Revenue Officer (CRO), Ross Seychell as Chief People Officer (CPeO), and Cho Hwang as Chief Technology Officer (CTO), strengthening its leadership team as the company enters its next phase of expansion. Cho Hwang joined Epassi on December 1, 2025. He brings extensive global technology leadership experience from companies including Hello...